Literature DB >> 1444650

Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy.

T Lerut1, P De Leyn, W Coosemans, D Van Raemdonck, I Scheys, E LeSaffre.   

Abstract

From 1975 through 1988, 257 patients with carcinoma of the thoracic esophagus have been treated in our department. Operability was 90% (232/257); overall resectability, 77% (198/257), and for the operated group, 85% (198/232). Hospital mortality rate was 9.6% but decreased to 3% over the period 1986 to 1988. There were 65% squamous cell epitheliomas and 35% adenocarcinomas. Tumor, nodes, and metastases (pTNM) staging was as follows: stage I, 11.6%; stage II, 23.2%; stage III, 37.9%; stage IV, 27.3%. Overall survival rate was 62.5% at 1 year, 42.4% at 2 years, and 30% at 5 years. According to the pTNM staging, 5-year survival was 90% for stage I, 56% for stage II, 15.3% for stage III, and 0 for stage IV. There were no statistically significant differences according to tumor localization, pathologic type, sex, or age. Introducing extensive resection and extended lymphadenectomy seems to improve significantly survival in patients in whom an operation with curative intention was performed, the 1 year survival rate being 90.8% versus 72%; 2-year survival, 81% versus 46%; and 5-year survival, 48.5% versus 41% for radical and nonradical resections, respectively. Based on multivariate Cox regression analysis, only TNM stage and presence or absence of lymph nodes are important factors in predicting survival: stage 1 tumors have lower risk, and involvement of lymph nodes creates higher risk. Using this analysis, there was only for the patients with involved lymph nodes (N1) a significantly better prognosis when a radical lymph node dissection was performed (p = 0.0055). Barrett adenocarcinomas have no worse prognosis than other esophageal carcinomas, with a 5-year survival rate of 91.5% if lymph nodes are negative, and a 54% overall 5-year survival rate. Functional results after restoration of continuity with gastric tubulation were judged excellent to very good in 86.5% at 1 year, but infra-aortic anastomoses have a much higher incidence of peptic esophagitis: 53% versus 8% for cervical anastomoses. From this study it can be concluded that in experienced hands surgery today offers the best chances for optimal staging, potential cure, and prolonged high-quality palliation.

Entities:  

Mesh:

Year:  1992        PMID: 1444650      PMCID: PMC1242677          DOI: 10.1097/00000658-199211000-00010

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

Review 1.  Surgical therapy of oesophageal carcinoma.

Authors:  J M Müller; H Erasmi; M Stelzner; U Zieren; H Pichlmaier
Journal:  Br J Surg       Date:  1990-08       Impact factor: 6.939

2.  Early and late functional results in patients with intrathoracic gastric replacement after oesophagectomy for carcinoma.

Authors:  P De Leyn; W Coosemans; T Lerut
Journal:  Eur J Cardiothorac Surg       Date:  1992       Impact factor: 4.191

3.  Function of the intrathoracic stomach as esophageal replacement.

Authors:  A H Hölscher; H Voit; G Buttermann; J R Siewert
Journal:  World J Surg       Date:  1988-12       Impact factor: 3.352

4.  The radiotherapy of carcinoma of the oesophagus and post cricoid region in south east Scotland.

Authors:  J G Pearson
Journal:  Clin Radiol       Date:  1966-07       Impact factor: 2.350

5.  En bloc esophagectomy: the first 100 patients.

Authors:  N K Altorki; D B Skinner
Journal:  Hepatogastroenterology       Date:  1990-08

6.  Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement.

Authors:  H Akiyama; M Tsurumaru; T Kawamura; Y Ono
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

7.  Long-term effects of hyperthermia combined with chemotherapy and irradiation for the treatment of patients with carcinoma of the esophagus.

Authors:  K Sugimachi; H Matsuda; S Ohno; A Fukuda; H Matsuoka; M Mori; H Kuwano
Journal:  Surg Gynecol Obstet       Date:  1988-10

Review 8.  Oesophogeal squamous cell carcinoms: II. A critical view of radiotherapy.

Authors:  R Earlam; J R Cunha-Melo
Journal:  Br J Surg       Date:  1980-07       Impact factor: 6.939

9.  Esophageal carcinoma: an aggressive approach.

Authors:  M H Drucker; K A Mansour; C R Hatcher; P N Symbas
Journal:  Ann Thorac Surg       Date:  1979-08       Impact factor: 4.330

10.  Palliative Nd:YAG laser therapy for cancer of the esophagus and gastroesophageal junction: impact on the quality of remaining life.

Authors:  P Rutgeerts; G Vantrappen; L Broeckaert; M Muls; K Geboes; G Coremans; J Janssens
Journal:  Gastrointest Endosc       Date:  1988 Mar-Apr       Impact factor: 9.427

View more
  50 in total

1.  Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years.

Authors:  N Ando; S Ozawa; Y Kitagawa; Y Shinozawa; M Kitajima
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

Review 3.  Pattern of lymphatic spread of Barrett's cancer.

Authors:  Marcus Feith; Hubert J Stein; J Rüdiger Siewert
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

4.  Does fibrin glue reduce lymph leakage (pleural effusion) after extended esophagectomy? Prospective randomized clinical trial.

Authors:  Mitsuo Tachibana; Shoichi Kinugasa; Hiroshi Yoshimura; Dipok Kumar Dhar; Shuhei Ueda; Toshiyuki Fujii; Hitoshi Kohno; Naofumi Nagasue
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

5.  How surgeons make decisions: authority and evidence.

Authors:  Huug Obertop
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

6.  Intravoxel incoherent motion diffusion-weighted imaging of resectable oesophageal squamous cell carcinoma: association with tumour stage.

Authors:  Yu-Cheng Huang; Tian-Wu Chen; Xiao-Ming Zhang; Nan-Lin Zeng; Rui Li; Yu-Lian Tang; Fan Chen; Yan-Li Chen
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

Review 7.  State of the art in thoracospic surgery: a personal experience of 2000 videothoracoscopic procedures and an overview of the literature.

Authors:  G C Roviaro; F Varoli; C Vergani; M Maciocco
Journal:  Surg Endosc       Date:  2002-02-28       Impact factor: 4.584

8.  Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.

Authors:  T Lerut; P Nafteux; J Moons; W Coosemans; G Decker; P De Leyn; D Van Raemdonck; N Ectors
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

Review 9.  Surgical management of esophageal malignancy.

Authors:  Dennis Blom
Journal:  Curr Gastroenterol Rep       Date:  2003-06

10.  Radical thoracoscopic esophagectomy for cancer.

Authors:  S P Dexter; I G Martin; M J McMahon
Journal:  Surg Endosc       Date:  1996-02       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.